Nuo Therapeutics, Inc. Balance Sheet
AURX|7 years of annual SEC 10-K data (FY2011-FY2017)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 7 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Total Assets
$1M
FY2017
Cash
$693,515
Cash and equivalents
Total Debt
N/A
FY2017
Shareholder Equity
$482,871
FY2017
Nuo Therapeutics, Inc. had $1M in total assets and $482,871 in shareholders' equity as of FY2017.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -45.34 (distress zone, below 1.23 threshold)
- Currently unprofitable: Net income is negative
- Cash-backed earnings: Operating cash flow exceeds net income
- Negative return on equity: -3102.0% ROE
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $693.5K | $10.4M | $922.3K | $15.9M | $3.3M | - | - |
| Inventory | $35.6K | $70.0K | $254.4K | $556.6K | $1.1M | $1.2M | $548.2K |
| Current Assets | $1.2M | $3.4M | $3.0M | $21.4M | $10.0M | $6.4M | $5.2M |
| PP&E (Net) | $223.6K | $486.1K | $1.1M | $925.2K | $919.5K | - | $978.9K |
| Goodwill | $0 | $2.1M | $0 | $0 | $1.1M | $1.1M | $706.8K |
| Total Assets | $1.4M | $14.1M | $7.1M | $56.2M | $46.3M | $44.3M | $10.1M |
| Current Liabilities | $936.8K | $1.4M | $42.2M | $8.5M | $10.6M | $2.8M | $3.1M |
| Shareholders' Equity | $482.9K | $12.5M | -$36.6M | $15.5M | $26.3M | $38.0M | $3.3M |